title: Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk.
abstract: NK cells are effector lymphocytes that can recognize and eliminate virally infected and transformed cells. NK cells express distinct activating receptors, including an ITAM-containing FcR complex that recognizes Ab-coated targets, and the DNAX-activating protein of 10 kDa-containing NKG2D receptor complex that recognizes stress-induced ligands. The regulatory role of specific tyrosine kinases in these pathways is incompletely understood. In this study, we show that, in activated human NK cells, the tyrosine kinase IL-2-inducible T cell kinase (Itk), differentially regulates distinct NK-activating receptors. Enhanced expression of Itk leads to increases in calcium mobilization, granule release, and cytotoxicity upon stimulation of the ITAM-containing FcR, suggesting that Itk positively regulates FcR-initiated cytotoxicity. In contrast, enhanced Itk expression decreases cytotoxicity and granule release downstream of the DNAX-activating protein of 10 kDa-containing NKG2D receptor, suggesting that Itk is involved in a pathway of negative regulation of NKG2D-initiated granule-mediated killing. Using a kinase mutant, we show that the catalytic activity of Itk is required for both the positive and negative regulation of these pathways. Complementary experiments where Itk expression was suppressed also showed differential regulation of the two pathways. These findings suggest that Itk plays a complex role in regulating the functions initiated by distinct NK cell-activating receptors. Moreover, understanding how these pathways may be differentially regulated has relevance in the setting of autoimmune diseases and antitumor immune responses where NK cells play key regulatory roles.
authors.affiliation: Department of Immunology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
authors.forename: Dianne
authors.initials: D
authors.lastname: Khurana
authors.forename: Laura N
authors.initials: LN
authors.lastname: Arneson
authors.forename: Renee A
authors.initials: RA
authors.lastname: Schoon
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Dick
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Leibson
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000201:enzymology / Q000235:genetics / Q000276:immunology; D020013:Calcium Signaling / Q000235:genetics / Q000276:immunology*; D045744:Cell Line, Tumor; D015971:Gene Expression Regulation, Enzymologic / Q000235:genetics; D006801:Humans; D007111:Immunity, Cellular / Q000235:genetics; D007694:Killer Cells, Natural / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D009154:Mutation; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics / Q000276:immunology; D011505:Protein-Tyrosine Kinases / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D011971:Receptors, Immunologic / Q000096:biosynthesis / Q000276:immunology
chemical_list: D011971:Receptors, Immunologic; D011505:Protein-Tyrosine Kinases; C080813:emt protein-tyrosine kinase